Aimei Health Technology Co., Ltd. AFJK

Financials SIC 6770 - Blank Checks NAICS Finance and Insurance › Funds, Trusts, and Other Financial Vehicles › Other Investment Pools and Funds › Other Financial Vehicles derived Nasdaq

Last close 12.06 2026-10-23
Market cap $38.2M 2026-06-30 share count
52-week range 6.75 - 130.37

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023
Operating income -$835.8K-$1.1M—
Pre-tax income $1.1M$2.6M—
Income tax $0$0$0
Net income $1.1M$2.6M—

Balance sheet

Fiscal year FY2025FY2024FY2023
Total current assets $2.9K$30.4K$580.7K
Total assets $12.1M$73.8M$70.5M
Total current liabilities $3.4M$817.0K$24.8K
Total liabilities $4.1M$1.5M$714.8K
Retained earnings -$4.1M-$1.5M-$134.3K
Total equity -$4.1M-$1.5M-$134.1K

Cash flow

Fiscal year FY2025FY2024FY2023
Operating cash flow -$565.1K-$672.3K—
Investing cash flow $63.6M-$277.7K—
Financing cash flow -$63.0M$397.5K—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-021108.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 1M 2M 3M Net income, FY2024: 2.6M Net income, FY2025: 1.1M FY2023 FY2024 FY2025
Fiscal year FY2023FY2024FY2025
Revenue — — —
Gross profit — — —
Net income — $2.6M $1.1M

Recent filings and events

  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
  • New debt or obligation Item 2.03
  • Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • New debt or obligation Item 2.03
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • New debt or obligation Item 2.03
  • Delisting notice Item 3.01
  • New debt or obligation Item 2.03
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Delisting notice Item 3.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 6770

TickerCompanyMarket capP/ERevenue growth
DMII Drugs Made In America Acquisition II Corp. $649.1M — —
IACO Idea Acquisition Corp. $437.9M — —
KRAQ KRAKacquisition Corp $430.8M — —
TACO Berto Acquisition Corp. $393.2M 36.1x —
ALDF Aldel Financial II Inc. $328.0M — —
ATII Archimedes Tech SPAC Partners II Co. $290.3M — —
FGII FG Imperii Acquisition Corp. $290.3M — —
SOUL Soulpower Acquisition Corp. $269.3M — —